Chemours Co
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.7% | 34.1% | -21.3% | -39.9% | 9.3% | 9.9% | -8.2% | 5.8% | 9.8% | 10.3% | -3.2% | 7.2% | 6.1% | |
| 5.1% | 5.5% | 5.2% | 4.8% | 5.2% | 5.6% | 6.4% | 5.7% | 5.3% | 25.6% | 5.7% | 10.0% | 11.3% | |
| 0.4% | 0.4% | 0.1% | 0.4% | 0.3% | 0.2% | 0.4% | 0.4% | 0.3% | 0.3% | 0.5% | 0.9% | 0.5% | |
| -4.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 6.9% | 8.2% | -28.7% | -46.9% | 0.9% | 3.9% | -15.7% | 18.5% | 0.2% | 6.9% | -5.9% | 17.3% | 5.0% | |
| 5.8% | 9.6% | 7.5% | 4.7% | 5.1% | 7.8% | 6.1% | 2.7% | 2.7% | 3.4% | 3.5% | 5.8% | 3.9% | |
| -6.7% | -9.2% | -7.4% | -4.5% | -5.0% | -7.7% | -6.3% | -2.6% | -2.3% | -3.2% | -3.2% | 12.3% | 1.3% | |
| 2.5% | 2.6% | 2.7% | 2.4% | 2.5% | 2.6% | 2.7% | 0.8% | 0.9% | 1.1% | 0.9% | 1.6% | 1.2% | |
| -1.2% | -0.1% | -0.1% | -0.1% | 0.2% | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| 25.2% | – | – | – | -1.6% | 9.3% | -3.4% | 1.4% | -1.3% | -1.4% | -0.4% | -16.8% | -5.4% | |
| 21.9% | -0.4% | -4.0% | -2.6% | -1.8% | 6.1% | -4.2% | -1.7% | -0.3% | -2.8% | -1.4% | -19.4% | -6.4% | |
| 33.8% | 25.5% | -33.3% | -47.2% | 3.1% | 7.0% | -18.2% | 2.4% | 7.5% | 4.4% | -7.9% | -0.1% | 1.1% | |
| 3.0% | 24.6% | -28.8% | -44.6% | 4.2% | 2.1% | -14.3% | 3.1% | 7.0% | 6.9% | -6.7% | 1.3% | 2.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.